ADIL
ADIAL PHARMACEUTICALS, INC.Company Information
- Company Name
- ADIAL PHARMACEUTICALS, INC.
- CIK
- CIK0001513525
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ADIL: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ADIL
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-09-29
- Last sale
- 2021-10-04
- Shares purchased (TTM)
- 700
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 35,546
- Shares outstanding
- 1,370,109
- Ownership
- 2.59%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 78.89%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Related Party | - | - | - | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | ||||||
Assets | |||||||||||||||||
| Accounts Receivable From Securitization | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Cash And Cash Equivalents At Carrying Value | 29 | 5 | 6 | 5 | 6 | 2 | 4 | 5 | 3 | 3 | 0 | ||||||
Assets Current | |||||||||||||||||
| Assets Current | 29 | 5 | 6 | 5 | 6 | 3 | 4 | 6 | 4 | 3 | 1 | ||||||
| Prepaid Expense Current | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Indefinite Lived Intangible Assets Excluding Goodwill | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Equity Method Investments | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Assets | 29 | 5 | 7 | 6 | 7 | 3 | 5 | 7 | 5 | 5 | 3 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||
| Accounts Payable Current | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | ||||||
Liabilities Current | |||||||||||||||||
| Accrued Liabilities And Other Liabilities | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities Current | 5 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Derivative Liabilities Noncurrent | 24 | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 29 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 39 | - | - | - | - | - | - | - | - | - | - | ||||||
Stockholders Equity | |||||||||||||||||
| Stockholders Equity | -38 | 4 | 5 | 5 | 6 | 2 | 4 | 6 | 4 | 4 | 2 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 106 | 96 | 95 | 92 | 92 | 86 | 86 | 86 | 82 | 73 | 69 | ||||||
| Retained Earnings Accumulated Deficit | -144 | -92 | -90 | -88 | -86 | -84 | -82 | -80 | -78 | -69 | -67 | ||||||
| Liabilities And Stockholders Equity | 29 | 5 | 7 | 6 | 7 | 3 | 5 | 7 | 5 | 5 | 3 | ||||||
| Redeemable Preferred Stock | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Outstanding | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 50 | 50 | 100 | 50 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialADIAL PHARMACEUTICALS, INC. (ADIL) — SEC Financial Statements & Analysis
ADIAL PHARMACEUTICALS, INC. (ADIL) is a pharmaceutical preparations company, incorporated in DE. ADIAL PHARMACEUTICALS, INC. trades on Nasdaq as: ADIL. ADIAL PHARMACEUTICALS, INC. (ADIL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, ADIAL PHARMACEUTICALS, INC. carries a market cap of $11.83M, a P/E ratio of -0.20x, a P/B ratio of -0.31x, an enterprise value of $-16.88M, and an EV/EBITDA multiple of 0.29x. On profitability, it posts a Return on Equity (ROE) of 352.59%, a Return on Assets (ROA) of -322.10%, and a Return on Invested Capital (ROIC) of -804.49%. Per share, it reports EPS of $-12.51, diluted EPS of $-12.51, free cash flow per share of $-2.41, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 287.26% year-over-year and EPS growth of -64.40% year-over-year. On the balance sheet, it maintains a current ratio of 5.63x, a quick ratio of 5.61x, working capital of $23.72M, a debt-to-equity ratio of -0.75x, a debt ratio of 0.99, free cash flow of $-11.13M (TTM), and net debt of $-28.71M. Figures sourced from SEC EDGAR.
- Market Cap
- $11.83M
- P/E TTM
- -0.20x
- EPS TTM
- $-12.51
- P/B TTM
- -0.31x
- ROE TTM
- 352.59%
- ROA TTM
- -322.10%
- Debt To Equity
- -0.75x
- Free Cash Flow TTM
- $-11.13M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ADIAL PHARMACEUTICALS, INC. in?
ADIAL PHARMACEUTICALS, INC. (ADIL) operates in the Pharmaceutical Preparations industry.
What exchange does ADIL trade on?
ADIAL PHARMACEUTICALS, INC. (ADIL) trades on the Nasdaq.
Where is ADIAL PHARMACEUTICALS, INC. incorporated?
ADIAL PHARMACEUTICALS, INC. is incorporated in DE.
When was ADIAL PHARMACEUTICALS, INC. (ADIL)'s most recent SEC filing?
ADIAL PHARMACEUTICALS, INC. (ADIL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ADIL's market cap?
ADIAL PHARMACEUTICALS, INC. (ADIL) has a market capitalization of $11.83M as of 2026-06-30.
What is ADIL's EPS (earnings per share)?
ADIAL PHARMACEUTICALS, INC. (ADIL)'s trailing twelve month EPS is $-12.51 as of 2026-06-30.
What is ADIL's ROE (return on equity)?
ADIAL PHARMACEUTICALS, INC. (ADIL)'s trailing twelve month Return on Equity (ROE) is 352.59% as of 2026-06-30.
What is ADIL's ROA (return on assets)?
ADIAL PHARMACEUTICALS, INC. (ADIL)'s trailing twelve month Return on Assets (ROA) is -322.10% as of 2026-06-30.
What is ADIL's ROIC (return on invested capital)?
ADIAL PHARMACEUTICALS, INC. (ADIL)'s trailing twelve month Return on Invested Capital (ROIC) is -804.49% as of 2024-12-31.
What is ADIL's EV/EBITDA?
ADIAL PHARMACEUTICALS, INC. (ADIL)'s trailing twelve month EV/EBITDA is 0.29x as of 2026-06-30.